E nīnau i ka mea loea: He aha e ʻike ai e pili ana i kāu HER2 + Diagnosis

Anter

• 1. He aha ke ʻano o ka manaʻo o HER2-positive?
• 2. E pono anei iaʻu ke ʻoki kino? Inā pēlā, he aha kaʻu mau koho?
• 3. He aha nā koho lapaʻau e loaʻa ai?
• 4. He aha nā pahuhopu o ka lapaʻau?
• 5. He aha ke kuanaʻike no ka HER2-maʻi maʻi ʻaʻai umauma?
• 6. Aia kekahi hopena o ka mālama ʻana, a pehea wau e hoʻokele ai iā lākou?
• 7. Aia kekahi mau hoʻololi nohona e pono iaʻu e hana ma hope o kaʻu kuhi?
• 8. He aha koʻu makaʻu i ka hoʻi hou ʻana o ka maʻi ʻaʻai umauma HER2-maikaʻi?

1. He aha ke ʻano o ka manaʻo o HER2-positive?

Kū ka HER2-maikaʻi i ka mea loaʻa o ka epidermal factor factor receptor 2. Loaʻa i nā cell i ke kino nā leka e ulu a pālahalaha ʻia mai nā mea loaʻa ma waho o ka cell. Hoʻomaopopo kēia mau mea loaʻa i nā ʻenemi like ʻole, a i ʻole nā ​​ʻelele, i hana ʻia i loko o ke kino. Hoʻoponopono nā mea loaʻa i nā hunaola ʻokoʻa a haʻi iā lākou i ka mea e hana ai (ʻo ia hoʻi, ulu, hoʻolaha, a make paha).

Aia kēia mau mea loaʻa ma waho o nā hunaola maʻi ʻaʻai. Akā, ʻoi aku ka nui o nā mea loaʻa ma ke kolamu maʻi ʻaʻai ma mua o kahi hunaola maʻamau. ʻO kēia helu māhuahua, a me nā hoʻololi ʻē aʻe e pili ana i ka pūnaeho maʻi ʻaʻai, e ʻae iā lākou e loaʻa i nā leka hou aʻe e ulu a pāhola ke hoʻohālikelike ʻia i nā ʻāpana maʻamau, noncancerous. Kāhea mākou i kēia mau mea loaʻa nā "oncodrivers," ʻo ia hoʻi ke kalaiwa nei lākou i ka maʻi ʻaʻai e ulu.

I kēia mau hihia, hiki i ka maʻi ʻaʻai ke hilinaʻi nui i kēlā mau mea loaʻa e hoʻomau i ka ulu a hoʻolaha. Ke ālai ʻia kēia mau mea loaʻa a ʻae ʻia e loaʻa nā leka, ʻaʻole hiki i ka cell ke ulu a pāhola paha.

I ka HER2-maʻi maikaʻi umauma maʻi 'aʻai, ka helu o ka HER2-maikaʻi nā mea loaʻa ma waho o ka pūnaewele ʻoi aku ka nui ma mua o ka mea i loko o kahi maʻamau, noncancerous cell. Kōkua kēia i ka hoʻoulu ʻana i ka maʻi ʻaʻai.

2. E pono anei iaʻu ke ʻoki kino? Inā pēlā, he aha kaʻu mau koho?

E hoʻoholo kāu hui oncology inā ʻoe e pono i ke ʻoki a kūkākūkā i ke ʻano o ke kaha ʻoi loa no ʻoe. Hoʻoholo nā kumu like ʻole he nui i ke ʻano o ke ʻoki e hana ai a i ka wā hea e ʻoki ai (ma mua a ma hope paha o ka hoʻoponopono ʻōnaehana). E kūkākūkā kāu mau kauka i kāu mau koho me ʻoe i ke kikoʻī, a hui pū, hiki iā ʻoe ke hoʻoholo.

3. He aha nā koho lapaʻau e loaʻa ai?

ʻO nā koho lapaʻau e laʻa me ka radiation radiation, ʻoki kino, chemotherapy, a me ka endocrine therapy. E hiki nō iā ʻoe ke komo i nā lāʻau lapaʻau e hōʻike kikoʻī ana i nā mea loaʻa ʻo HER2.

Hoʻoholo nā kumu he nui i ke ʻano a me ka lōʻihi o ka mālama ʻana e loaʻa iā ʻoe. Hoʻopili kēia i kou mau makahiki, nā kūlana olakino ʻē aʻe, ke kahua o ka maʻi ʻaʻai, a me kāu mau makemake ponoʻī. Pono kāu hui oncology e kūkākūkā i nā koho lapaʻau a pau i loaʻa no kāu hihia kikoʻī.

4. He aha nā pahuhopu o ka lapaʻau?

ʻO nā pahuhopu o ka mālama ʻana e pili i ka pae o ka maʻi ʻaʻai o ka umauma i loaʻa iā ʻoe ma ka hōʻailona. No ka poʻe me ka pae 0 i ka maʻi ʻaʻai umauma 3, ʻo ka pahuhopu o ka mālama ʻana e hōʻola i ka maʻi ʻaʻai a pale i ka hoʻi hou ʻana o ka wā e hiki mai ana.

ʻO ka maʻi maʻi umauma pae 4 ʻo ia hoʻi ka maʻi maʻi i hohola ma ʻō aku o ka umauma a me nā lymph node kūloko. I kēia wā, ʻo ka pahuhopu o ka mālama ʻana ka mālama ʻana i ka ulu ʻana o ka maʻi ʻaʻai a pale i nā hōʻino a nā ʻino a me nā ʻeha.

Minamina, ʻaʻole hiki ke hoʻōla ʻia ka maʻi ʻaʻai ʻehā. Akā me ka hōʻea ʻana mai o nā lāʻau hou a me nā mea hou, hiki ke noho i kahi manawa o ka maʻi kūpaʻa no nā wā lōʻihi.

5. He aha ke kuanaʻike no ka HER2-maʻi maʻi ʻaʻai umauma?

ʻO ka nānā no ka HER2-maikaʻi umauma maʻi 'aʻai hilinaʻi ʻia i kekahi mau kumu ʻokoʻa. Hoʻopili kēia i ke kahua o ka maʻi ʻaʻai, kou hiki ke hoʻomanawanui i nā mālama ʻana, kou mau makahiki, a me kou kūlana olakino o kēia manawa.

ʻO ka hōʻea ʻana o nā lāʻau lapaʻau hou a maikaʻi i hana ʻia me ka hui pū me nā lāʻau ʻē aʻe e hoʻomau i ka hoʻomaikaʻi i nā hiʻohiʻona no nā wahine me ka maʻi maʻi umauma HER2-maikaʻi.

6. Aia kekahi hopena o ka mālama ʻana, a pehea wau e hoʻokele ai iā lākou?

E pili ka hopena i ka hopena ma ke ʻano o ka hana. Ma ke ʻano laulā, hiki i nā mea maʻi ke hoʻomanawanui i nā antibodies monoclonal i hoʻohana ʻia e hoʻokele pono iā HER2-mau reseptor maikaʻi.

ʻO kekahi mau hopena ʻē aʻe e pili ana i ka luhi, ʻeha pū, ka ʻeha, a me ka hiamoe ʻole. ʻO ka hapa nui o kēia mau hopena ʻaoʻao liʻiliʻi i ka paʻakikī.

Kākaʻikahi wale nō, nā monamona pilikino i hoʻohana ʻia e mālama iā HER2-maikaʻi i ka maʻi ʻaʻai umauma i hiki ke hoʻonāwaliwali i nā mākala puʻuwai. E kūkākūkā kāu hui oncology i kēia pilikia me ʻoe a e nānā pono iā ʻoe no nā hōʻailona o kēia pilikia launa ʻole.

7. Aia kekahi mau hoʻololi nohona e pono iaʻu e hana ma hope o kaʻu kuhi?

Ma ke ʻano laulā, pono ʻoe e hāhai i kahi nohona olakino ma hope o ka ʻike ʻana i ka maʻi ʻaʻai umauma E hōʻoki i ka puhi inā puhā ʻoe, e kaupalena i ka lawe ʻana i ka waiʻona i hoʻokahi inu a i ʻole emi iki i kēlā me kēia lā, a hana i ka hoʻoikaika kino i kēlā me kēia lā.

E mālama pū ʻoe i ka papaʻai olakino i kiʻekiʻe i nā hua, nā mea kanu, a me nā protein momona momona. E kaupalena i kāu lawe ʻana i nā kō a me nā meaʻai i hoʻopiha ʻia i ka momona.

8. He aha koʻu makaʻu i ka hoʻi hou ʻana o ka maʻi ʻaʻai umauma HER2-maikaʻi?

I nā mea maʻi me ka maʻi ʻōpū mua HER2-maikaʻi maʻi maʻi (pae 0 a 3), ke ola nei ka hoʻi hou ʻana he 10 mau makahiki mai 79 a 95 pakeneka. Aia ka pae i ka pae o ka maʻi ʻaʻai a me ke ʻano o ke ʻoki.

Eia nō naʻe, hiki i nā kumu he nui ke hāʻawi i kāu pilikino i ka hoʻi hou ʻana. Kūkākūkā i kāu pilikia pilikino me kāu kime oncology.

ʻO nā ʻōlelo aʻoaʻo i hāʻawi ʻia e Hope Qamoos, kahi kahu hānai i ke olakino wahine. Loaʻa ka manaolana ma mua o 15 mau makahiki o ka hana i ka olakino a me ka oncology o nā wahine. Ua hoʻohana ʻo ia i kāna ʻoihana ʻoihana e hana pū ana me nā alakaʻi manaʻo nui i ka māla ma nā haukapila kula e like me Stanford, Northwestern, a me Loyola. Hoʻohui ʻia, hana pū ʻo Hope me kahi hui multidisciplinary me ka pahuhopu e hoʻomaikaʻi i ka mālama ʻana o nā wahine me ka maʻi ʻaʻai ma Nigeria.